Ramco Resources (NASDAQ:METC) shares are pulling back after an enormous August rally that saw the stock surge more than 55% for the month on the back of blowout earnings and strong momentum in metallurgical coal names alongside peer Peabody Energy (NYSE:BTU). Today's pullback comes …
Tamboran Resources (NYSE:TBN) shares are trading sharply higher after the Sturt Plateau Compression Facility Trust, a 50/50 joint venture between Tamboran and Daly Waters Infrastructure, began gas commissioning at the facility using gas from wells on the Shenandoah South 2 pad. The SPCF is …
Vista Energy (NYSE:VIST) shares are trading higher alongside a broad energy-sector surge, driven by escalating U.S.-Iran military tensions that pushedBrent Crudeabove $92 per barrel and fueled gains across oil and gas producers. Investor attention is also focused on a newly disclosed 13F stake from …
Roland Thomas Kelly, Chief Legal Officer and General Counsel of Velocity Financial, Inc. (NYSE:VEL), filed a Form 4 on September 1, 2026, disclosing the sale of 1,600 shares of common stock on that same date pursuant to a Rule 10b5-1 trading plan.
Stephen Kenneth Parker, Executive Vice President, President and CEO of Boeing Defense, Space and Security, filed a Form 4 with the SEC on September 1, 2026, disclosing a change in beneficial ownership of Boeing Co common stock dated August 28, 2026.
Scott D. Lipesky, Executive Vice President and Chief Operating Officer of Abercrombie & Fitch Co /DE/ (NYSE:ANF), filed a Form 4 on September 1, 2026, reporting the sale of 5,000 shares of Class A Common Stock on August 28, 2026.
Jay Rust, Executive Vice President and Chief HR Officer of Abercrombie & Fitch Co /DE/, filed a Form 4 on September 1, 2026, disclosing the sale of 5,000 shares of Class A Common Stock on August 28, 2026.
A Form 4 filed with the SEC on September 1, 2026 discloses that Kenneth B. Robinson, a director of Abercrombie & Fitch Co /DE/ (NYSE:ANF), sold 800 shares of Class A Common Stock on August 28, 2026.
Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NASDAQ:NRIX), filed a Form 4 on September 1, 2026, disclosing the exercise of stock options and a same-day sale of 1,452 shares of common stock pursuant to a Rule 10b5-1 trading plan.
A Form 4 filed on September 1, 2026, discloses that William Gossman, a director of nLIGHT, Inc. (NASDAQ:LASR), exercised stock options and sold 15,000 shares of common stock on August 28, 2026, pursuant to a Rule 10b5-1 trading plan.